 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/01/2023 |
$8.36 |
$8.75 |
$8.11 |
$8.70 |
697.70K | | 06/02/2023 |
$8.80 |
$9.12 |
$8.43 |
$8.79 |
1.31M | | 06/05/2023 |
$8.73 |
$9.35 |
$8.54 |
$9.17 |
552.50K | | 06/06/2023 |
$9.17 |
$9.61 |
$9.04 |
$9.50 |
647.50K | | 06/07/2023 |
$9.51 |
$9.67 |
$9.29 |
$9.38 |
494.00K |
|
|
| Aclaris Therapeutics is a biopharmaceutical company that develops drug candidates for immuno-inflammatory diseases. Co.'s pipeline of drug candidates includes Zunsemetinib, which is for the indication of rheumatoid arthritis (moderate to severe), psoriatic arthritis (moderate to severe), and hidradenitis suppurativa (moderate to severe); ATI-1777, which is for the indication of atopic dermatitis (moderate to severe); ATI-2138, which is for the indication of T cell-mediated autoimmune diseases; Gut-Biased Program, which is for the indication of inflammatory bowel disease; and ATI-2231, which is for the indication of metastatic breast cancer and pancreatic cancer. | |
|
Aclaris Therapeutics (ACRS) has the following price history information. Looking back at ACRS historical stock prices for the last five trading days, on June 01, 2023, ACRS opened at $8.36, traded as high as $8.75 and as low as $8.11, and closed at $8.70. Trading volume was a total of 697.70K shares. On June 02, 2023, ACRS opened at $8.80, traded as high as $9.12 and as low as $8.43, and closed at $8.79. Trading volume was a total of 1.31M shares. On June 05, 2023, ACRS opened at $8.73, traded as high as $9.35 and as low as $8.54, and closed at $9.17. Trading volume was a total of 552.50K shares. On June 06, 2023, ACRS opened at $9.17, traded as high as $9.61 and as low as $9.04, and closed at $9.50. Trading volume was a total of 647.50K shares. On June 07, 2023, ACRS opened at $9.51, traded as high as $9.67 and as low as $9.29, and closed at $9.38. Trading volume was a total of 494.00K shares.
ACRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aclaris Therapeutics shares, starting with a $10,000 purchase of ACRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/07/2015 |
|
| End date: |
06/07/2023 |
|
| Start price/share: |
$11.05 |
|
| End price/share: |
$9.38 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-15.11% |
|
| Average Annual Total Return: |
-2.11% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,490.86 |
|
| Years: |
7.67 |
|
|
|
| Date |
Close |
| 06/01/2023 | $8.70 | | 06/02/2023 | $8.79 | | 06/05/2023 | $9.17 | | 06/06/2023 | $9.50 | | 06/07/2023 | $9.38 |
|
|
Free ACRS Email Alerts:
